Skip to main content

Table 2 Relative abundance of bacteria of colonic samples

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Bacterial taxa Sham SBS GLP2.SBS
Bacteroidetes.P
 Bacteroides.G 0.55 (0.42–1.12) 0.00 (0.00–0.01) * 0.00 (0.00–0.00) **
 Odoribacter.G 0.75 (0.48–1.15) 0.00 (0.00–0.00) ** 0.00 (0.00–0.00) **
 Prevotella.G 6.40 (4.63–8.32) 0.00 (0.00–0.00) ** 0.00 (0.00–0.02) *
Firmicutes.P
 Lachnospiraceae.F 3.35 (2.49–4.01) 0.00 (0.00–0.21) * 0.02 (0.00–0.20) *
 Coprococcus.G 0.44 (0.23–0.63) 0.00 (0.00–0.00) ** 0.00 (0.00–0.00) **
 Dorea.G 0.04 (0.02–0.36) 0.00 (0.00–0.00) ** 0.0000 (0.00–0.00) **
 Ruminococcaceae.F 5.73 (4.48–7.34) 0.00 (0.00–0.00) * 0.00 (0.00–0.00) *
 Oscillospira.G 1.55 (1.23–1.98) 0.00 (0.00) ** 0.00 (0.00) *
 Ruminococcus.G 1.70 (1.29–2.34) 0.00 (0.00–0.00) * 0.00 (0.00–0.00) *
 Clostridium.G 0.09 (0.05) 15.10 (11.40) ** 33.55 (12.67) ***#
Verrucomicrobia.P
 Akkermansia.G 33.90 (23.69–39.75) 0.00 (0.00–0.00) * 0.00 (0.00–0.00) *
Proteobacteria.P
 Proteus.G 0.00 (0.00–0.00) 2.01 (1.23–2.37) ** 0.02 (0.02–0.05) #
  1. Data were expressed as percentages of total sequences. For data passed normality test, one-way ANOVA and Tukey’s multiple comparisons test were used, and data were shown as mean (SD). Otherwise, Kruskal-Wallis and Dunn’s multiple comparisons test were used, and data were shown as median and IQR
  2. .P Phylum, F Family, G Genus
  3. *P < 0.05; **P < 0.01; ***P < 0.001 compared with Sham group; #P < 0.05 compared with SBS group